Asian equity markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.83% while the Hang Seng is up 0.29%. The Nikkei 225 is trading up by 0.11%. The US markets ended on a high note with the Nasdaq Composite hitting a record high on Tuesday while Goldman Sachs Group dragged the Dow lower on lower earnings.

Back home, share markets in India have opened the day on a positive note. The BSE Sensex is trading higher by 126 points while the NSE Nifty is trading higher by 43 points. The BSE Mid Cap Index and BSE Small Cap index opened the day up by 0.4% & 0.5% respectively.

All sectoral indices have opened the day in green with healthcare stocks and FMCG stocks leading the gainers. The rupee is trading at 64.33 to the US$.

Aurobindo Pharma share price surged 5.7% after it was reported that the pharma major has been granted USFDA nod for tablet version of gRenvela. As per IMS data, market size for drug stands at US$1.8 billion.

Power stocks opened the day on a mixed note with NHPC Ltd and PTC India Ltd leading the gains. As per an article in Livemint, Tata Power Co. Ltd is planning to invest around US$90 million in equity capital in its renewable energy arm Tata Power Renewable Energy Ltd (TPREL) as the company seeks to develop its immediate pipeline of 320 megawatts (MW) of solar assets.

Presently, TPREL owns around 2 gigawatts (GW) of solar and wind assets, including the assets that it acquired from Welspun Energy. In all, Tata Power owns over 3GW of green assets, including its hydropower assets.

The pipeline of projects, which is worth around 320MW, is spread across six projects in the states of Telangana, Andhra Pradesh, Karnataka, Gujarat and Maharashtra.

Reportedly, deep-pocketed investors such as pension funds and sovereign wealth funds, attracted by the scale of the renewable opportunity in India, have backed large renewable platforms in recent years.